Teva Pharmaceutical Industries has seen its fair value price target rise from $24.44 to $27.45, reflecting renewed optimism ...

Teva stock jumps after third-quarter earnings and revenues top estimates, driven by robust Austedo sales as well as U.S. generics growth.

There is basically no research that looks at the impact of antidepressants on emerging sexuality. Here are the key things we ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

Doctors push back on unfounded claims that antidepressants are addictive, cause violence or are a cure-all.

Research on adults who take S.S.R.I.s shows they tamp down sexual desire. Why aren’t we studying what that could mean for adolescents who take them?

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

Eli Lilly has made the decision to discontinue manufacturing its migraine therapy Reyvow (lasmiditan), according to the FDA’s Drug Shortages tracker.

Dominic Cipriano couldn't stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was ...

Dominic Cipriano couldn’t stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was ...